\-\ Texto\\:\\ \ \(0\)\
\-\ surgical\\ resection\\ curative\\.\\ nsaids\\ or\\ steroids\\ to\\ calm\\ inflammation\\ in\\ cases\\ of\\ rupture\ \(0\)\
\-\ well\\ circumscribed\\ mass\\ within\\ the\\ left\\ lacrimal\\ fossa\\ which\\ follows\\ fat\\ signal\\ intensity\\ on\\ all\\ sequences\\.\ \(0\)\
\-\ orbital\\ dermoid\ \(1\)\
\-\ ddx\\ for\\ lacrimal\\ gland\\ lesion\\:\ \(0\)\
\-\ more\\ common\\ \\(abscess\\/hematoma\\,\\ orbital\\ pseudotumor\\,\\ lymphoma\\,\\ lacrimal\\ benign\\ mixed\\ tumor\\)\ \(0\)\
\-\ less\\ common\\ \\(dermoid\\ cyst\\,\\ sarcoid\\,\\ sjogren\\ syndrome\\,\\ adenoid\\ cystic\\ carcinoma\\,\\ pleomorphic\\ adenoma\\)\\.\ \(0\)\
\-\ 26\\ yo\\ male\\ with\\ chronic\\ diffuse\\ headache\\,\\ incidental\\ left\\ orbital\\ finding\\ is\\ noted\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lacrimal\\:\\ 0\\.4795656630777861\ \(0\)\
\-\ orbital\\:\\ 0\\.3543711743537933\ \(0\)\
\-\ dermoid\\:\\ 0\\.22751105964778562\ \(0\)\
\-\ calm\\:\\ 0\\.20579485533070221\ \(0\)\
\-\ sjogren\\:\\ 0\\.17985848472867572\ \(0\)\
\-\ adenoid\\:\\ 0\\.16484386990730554\ \(0\)\
\-\ curative\\:\\ 0\\.1577075318200037\ \(0\)\
\-\ common\\:\\ 0\\.15274702072870608\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.13985195732318167\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.13628165093054267\ \(0\)\
\-\ nsaids\\:\\ 0\\.13177116121797716\ \(0\)\
\-\ follows\\:\\ 0\\.13177116121797716\ \(0\)\
\-\ ddx\\:\\ 0\\.1279857435246227\ \(0\)\
\-\ sarcoid\\:\\ 0\\.12629871872816362\ \(0\)\
\-\ steroids\\:\\ 0\\.11831644668681993\ \(0\)\
\-\ mixed\\:\\ 0\\.1114764332957036\ \(0\)\
\-\ gland\\:\\ 0\\.10939811540217524\ \(0\)\
\-\ 26\\:\\ 0\\.10939811540217524\ \(0\)\
\-\ rupture\\:\\ 0\\.10887346487939023\ \(0\)\
\-\ inflammation\\:\\ 0\\.10823363433862769\ \(0\)\
\-\ sequences\\:\\ 0\\.1077339690859622\ \(0\)\
\-\ adenoma\\:\\ 0\\.10736604005080458\ \(0\)\
\-\ fossa\\:\\ 0\\.10572101544674002\ \(0\)\
\-\ circumscribed\\:\\ 0\\.10428977107121513\ \(0\)\
\-\ incidental\\:\\ 0\\.09982577271262333\ \(0\)\
\-\ intensity\\:\\ 0\\.0956248537615123\ \(0\)\
\-\ headache\\:\\ 0\\.09283597470262916\ \(0\)\
\-\ benign\\:\\ 0\\.09250943696691566\ \(0\)\
\-\ left\\:\\ 0\\.09187798306010815\ \(0\)\
\-\ less\\:\\ 0\\.09161845190940111\ \(0\)\
\-\ cases\\:\\ 0\\.09057988565994303\ \(0\)\
\-\ finding\\:\\ 0\\.08852071467254366\ \(0\)\
\-\ resection\\:\\ 0\\.08632544245762874\ \(0\)\
\-\ diffuse\\:\\ 0\\.08445497472045753\ \(0\)\
\-\ yo\\:\\ 0\\.08413439149478347\ \(0\)\
\-\ fat\\:\\ 0\\.08377326320025613\ \(0\)\
\-\ syndrome\\:\\ 0\\.08118753089620602\ \(0\)\
\-\ cystic\\:\\ 0\\.0811073668058767\ \(0\)\
\-\ carcinoma\\:\\ 0\\.08055371291167572\ \(0\)\
\-\ lymphoma\\:\\ 0\\.08020452870334434\ \(0\)\
\-\ all\\:\\ 0\\.08016604735510421\ \(0\)\
\-\ chronic\\:\\ 0\\.07993646724523447\ \(0\)\
\-\ cyst\\:\\ 0\\.07768635574452692\ \(0\)\
\-\ signal\\:\\ 0\\.07634078921993503\ \(0\)\
\-\ more\\:\\ 0\\.07394842289613257\ \(0\)\
\-\ noted\\:\\ 0\\.07140201924667954\ \(0\)\
\-\ tumor\\:\\ 0\\.07044040346507356\ \(0\)\
\-\ surgical\\:\\ 0\\.06545418017723818\ \(0\)\
\-\ well\\:\\ 0\\.06520804447855945\ \(0\)\
\-\ lesion\\:\\ 0\\.06456395878408568\ \(0\)\
\-\ within\\:\\ 0\\.062025007736186834\ \(0\)\
\-\ which\\:\\ 0\\.0612359453649552\ \(0\)\
\-\ male\\:\\ 0\\.059960417726386626\ \(0\)\
\-\ mass\\:\\ 0\\.05144047638716276\ \(0\)\
\-\ or\\:\\ 0\\.04684941471769055\ \(0\)\
\-\ for\\:\\ 0\\.04081754774210224\ \(0\)\
\-\ on\\:\\ 0\\.04067275549481339\ \(0\)\
\-\ is\\:\\ 0\\.036880388680499934\ \(0\)\
\-\ to\\:\\ 0\\.03366732148962408\ \(0\)\
\-\ in\\:\\ 0\\.03350161100297957\ \(0\)\
\-\ the\\:\\ 0\\.026871613381470896\ \(0\)\
\-\ with\\:\\ 0\\.02637013700113266\ \(0\)\
\-\ of\\:\\ 0\\.026354390259232672\ \(0\)\
